XRCC5_MOUSE - dbPTM
XRCC5_MOUSE - PTM Information in dbPTM
Basic Information of Protein
UniProt ID XRCC5_MOUSE
UniProt AC P27641
Protein Name X-ray repair cross-complementing protein 5
Gene Name Xrcc5
Organism Mus musculus (Mouse).
Sequence Length 732
Subcellular Localization Nucleus . Nucleus, nucleolus . Chromosome .
Protein Description Single-stranded DNA-dependent ATP-dependent helicase. Has a role in chromosome translocation. The DNA helicase II complex binds preferentially to fork-like ends of double-stranded DNA in a cell cycle-dependent manner. It works in the 3'-5' direction. Binding to DNA may be mediated by XRCC6. Involved in DNA non-homologous end joining (NHEJ) required for double-strand break repair and V(D)J recombination. The XRCC5/6 dimer acts as regulatory subunit of the DNA-dependent protein kinase complex DNA-PK by increasing the affinity of the catalytic subunit PRKDC to DNA by 100-fold. The XRCC5/6 dimer is probably involved in stabilizing broken DNA ends and bringing them together. The assembly of the DNA-PK complex to DNA ends is required for the NHEJ ligation step. In association with NAA15, the XRCC5/6 dimer binds to the osteocalcin promoter and activates osteocalcin expression. The XRCC5/6 dimer probably also acts as a 5'-deoxyribose-5-phosphate lyase (5'-dRP lyase), by catalyzing the beta-elimination of the 5' deoxyribose-5-phosphate at an abasic site near double-strand breaks. XRCC5 probably acts as the catalytic subunit of 5'-dRP activity, and allows to 'clean' the termini of abasic sites, a class of nucleotide damage commonly associated with strand breaks, before such broken ends can be joined. The XRCC5/6 dimer together with APEX1 acts as a negative regulator of transcription. Plays a role in the regulation of DNA virus-mediated innate immune response by assembling into the HDP-RNP complex, a complex that serves as a platform for IRF3 phosphorylation and subsequent innate immune response activation through the cGAS-STING pathway..
Protein Sequence MAWSGNKAAVVLCVDVGVAMGNSFPGEESPIEQAKKVMTMFVQRQVFSESKDEIALVLYGTDGTDNALAGKDQYQNITVCRHLMLPDFDLLEDIGNKIQPSSQQADFLDALIVCMDLIQRETIGKKFGKKHIEVFTDLSSPFSQDQLDVIICNLKKSGISLQFFLPFPIDKNGEPGERGDLDSGLDHLKPSFPQKGLTEQQKEGIRMVTRVMLSLEGEDGLDEIYSFSESLRQLCVFKKIERRSMPWPCQLTIGPNLSIKIVAYKSIVQEKFKKSWVVVDARTLKKEDIQKETVYCLNDDDETEVSKEDTIQGYRYGSDIIPFSKVDEEQMKYKSEGKCFSVLGFCKSSQVHRRFFMGHQVLKVFAAKDDEAAAVALSSLVHALDELNMVAIVRYAYDKRSNPQVGVAFPYIKDAYECLVYVQLPFMEDLRQYMFSSLKNNKKCTPTEAQLSAIDDLIDSMSLVKKNEEEDIVEDLFPTSKIPNPEFQRLYQCLLHRALHLQERLPPIQQHILNMLDPPTEMKAKCESPLSKVKTLFPLTEVIKKKNQVTAQDVFQDNHEEGPAAKKYKTEKEEDHISISSLAEGNITKVGSVNPVENFRFLVRQKIASFEEASLQLISHIEQFLDTNETLYFMKSMDCIKAFREEAIQFSEEQRFNSFLEALREKVEIKQLNHFWEIVVQDGVTLITKDEGPGSSITAEEATKFLAPKDKAKEDTTGPEEAGDVDDLLDMI
Overview of Protein Modification Sites with Functional and Structural Information
Experimental Post-Translational Modification Sites

* ASA = Accessible Surface Area

Locations Modification Substrate Peptides
&
Secondary Structure
ASA (%) Reference Orthologous
Protein Cluster
244PhosphorylationFKKIERRSMPWPCQL
HHHCCCCCCCCCCEE
35.1026643407
258PhosphorylationLTIGPNLSIKIVAYK
EEECCCCEEEEEEEH
28.60-
265AcetylationSIKIVAYKSIVQEKF
EEEEEEEHHHHHHHH
24.7823236377
265MalonylationSIKIVAYKSIVQEKF
EEEEEEEHHHHHHHH
24.7826320211
275PhosphorylationVQEKFKKSWVVVDAR
HHHHHHCCEEEEECC
26.2029899451
283PhosphorylationWVVVDARTLKKEDIQ
EEEEECCCCCHHHCC
44.6529899451
306UbiquitinationDDDETEVSKEDTIQG
CCCCCEECHHHCCCC
24.8927667366
316PhosphorylationDTIQGYRYGSDIIPF
HCCCCCCCCCCEECH
16.7026643407
318PhosphorylationIQGYRYGSDIIPFSK
CCCCCCCCCEECHHH
19.3926643407
324PhosphorylationGSDIIPFSKVDEEQM
CCCEECHHHCCHHHH
26.8126643407
325UbiquitinationSDIIPFSKVDEEQMK
CCEECHHHCCHHHHC
54.8322790023
332AcetylationKVDEEQMKYKSEGKC
HCCHHHHCCCCCCCE
49.587713933
333PhosphorylationVDEEQMKYKSEGKCF
CCHHHHCCCCCCCEE
17.8826643407
528PhosphorylationEMKAKCESPLSKVKT
HHHHHCCCCHHHHHH
40.3828833060
531PhosphorylationAKCESPLSKVKTLFP
HHCCCCHHHHHHHHH
38.4928066266
535PhosphorylationSPLSKVKTLFPLTEV
CCHHHHHHHHHHHHH
36.30-
544UbiquitinationFPLTEVIKKKNQVTA
HHHHHHHHHCCCCCH
63.9722790023
578PhosphorylationEKEEDHISISSLAEG
CCCCCCEEHHHHHCC
17.0110026262
580PhosphorylationEEDHISISSLAEGNI
CCCCEEHHHHHCCCC
16.71-
581PhosphorylationEDHISISSLAEGNIT
CCCEEHHHHHCCCCE
29.9010026262
592PhosphorylationGNITKVGSVNPVENF
CCCEEEECCCCCCCH
23.0023140645
666AcetylationFLEALREKVEIKQLN
HHHHHHHHHCHHHHC
38.44-
716PhosphorylationKDKAKEDTTGPEEAG
CCCCCCCCCCHHHCC
34.4410026262
717PhosphorylationDKAKEDTTGPEEAGD
CCCCCCCCCHHHCCC
64.1625338131

Upstream regulatory proteins (kinases for phosphorylation sites, E3 ubiquitin ligases of ubiquitination sites, ...)
Modified Location Modified Residue Modification Type of Upstream Proteins Gene Name of Upstream Proteins UniProt AC of Upstream Proteins Sources
578SPhosphorylationKinasePRKDCP97313
Uniprot
580SPhosphorylationKinasePRKDCP97313
Uniprot
581SPhosphorylationKinasePRKDCP97313
Uniprot
716TPhosphorylationKinasePRKDCP97313
Uniprot

Functions of PTM Sites
Modified Location Modified Residue Modification Function Reference

Oops, there are no descriptions of PTM sites of XRCC5_MOUSE !!

Disease-associated PTM Sites based on SAP

* Distance = the distance between SAP position and PTM sites.

Modified Location Modification Variant Position
(Distance <= 10)
Residue Change SAP Related Disease Reference

Oops, there are no SNP-PTM records of XRCC5_MOUSE !!

Protein-Protein Interaction
Interacting Protein Gene Name Interaction Type PPI Reference Domain-Domain Interactions
TERF1_MOUSETerf1genetic
22556254
TERF2_MOUSETerf2genetic
22556254

Drug and Disease Associations
Kegg Drug
DrugBank
There are no disease associations of PTM sites.
Regulatory Network of XRCC5_MOUSE

loading...

Related Literatures of Post-Translational Modification

TOP